Valmark Advisers Inc. Purchases New Holdings in Cardinal Health, Inc. $CAH

Valmark Advisers Inc. purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 1,679 shares of the company’s stock, valued at approximately $282,000.

A number of other large investors also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health during the 1st quarter valued at about $26,000. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. GW&K Investment Management LLC increased its stake in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares in the last quarter. NBC Securities Inc. bought a new stake in Cardinal Health during the 1st quarter valued at about $48,000. Finally, Garde Capital Inc. bought a new stake in Cardinal Health during the 1st quarter valued at about $52,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.2%

Shares of CAH stock opened at $156.86 on Friday. The company has a 50 day moving average price of $152.09 and a 200-day moving average price of $151.09. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The firm has a market capitalization of $37.27 billion, a PE ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares of the company’s stock, valued at $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CAH. Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 12th. Citigroup restated a “neutral” rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Leerink Partners raised their price objective on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Finally, Evercore ISI reduced their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.